Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Radiology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
World Neurosurg. 2019 Nov;131:e247-e254. doi: 10.1016/j.wneu.2019.07.121. Epub 2019 Jul 23.
To explore the performance of neurite orientation dispersion and density imaging (NODDI) in grading gliomas and to evaluate the cellular proliferation.
NODDI and diffusion-weighted imaging were performed on 79 patients with histopathologically proven gliomas. Parameter maps of intracellular volume fraction (ICVF), orientation dispersion index (ODI), and apparent diffusion coefficient (ADC) were calculated. Regions of interest were placed in the most solid part of the tumor. These metrics were normalized to the contralateral normal-appearing white matter and correlated with Ki-67 expression.
ICVF and ODI increased as tumor grades increased, whereas ADC decreased with the increase of tumor grades. Significant differences in normalized ICVF and ODI were observed between low-grade gliomas and high-grade gliomas (ICVF: 0.208 ± 0.104 vs. 0.718 ± 0.234; ODI: 0.952 ± 0.428 vs. 1.767 ± 0.636, P < 0.001, respectively) and between grades II and III (ICVF: 0.208 ± 0.104 vs. 0.603 ± 0.253; ODI: 0.952 ± 0.428 vs. 1.762 ± 0.542, P < 0.001, respectively). Normalized ICVF was also significantly different between grades III and IV (0.603 ± 0.253 vs. 0.803 ± 0.182, P = 0.004). Ki-67 labeling index was positively correlated with normalized ICVF and ODI (r = 0.755 and 0.572, P < 0.001, respectively), and negatively correlated with normalized ADC (r = -0.709, P < 0.001).
NODDI is a promising method in grading gliomas and predicting cellular proliferation. These results may be of great significance for the clinical diagnosis and treatment of gliomas.
探讨神经突方向分散与密度成像(NODDI)在胶质瘤分级中的性能,并评估细胞增殖情况。
对 79 例经组织病理学证实的胶质瘤患者进行 NODDI 和弥散加权成像。计算细胞内容积分数(ICVF)、方向分散指数(ODI)和表观扩散系数(ADC)的参数图。在肿瘤最实性部分放置感兴趣区。这些指标与 Ki-67 表达进行归一化,并进行相关性分析。
随着肿瘤分级的升高,ICVF 和 ODI 增加,而 ADC 随肿瘤分级的升高而降低。低级别胶质瘤和高级别胶质瘤之间(ICVF:0.208 ± 0.104 vs. 0.718 ± 0.234;ODI:0.952 ± 0.428 vs. 1.767 ± 0.636,P < 0.001)以及 2 级和 3 级之间(ICVF:0.208 ± 0.104 vs. 0.603 ± 0.253;ODI:0.952 ± 0.428 vs. 1.762 ± 0.542,P < 0.001)的归一化 ICVF 和 ODI 差异均有统计学意义。3 级和 4 级之间的归一化 ICVF 也有显著差异(0.603 ± 0.253 vs. 0.803 ± 0.182,P = 0.004)。Ki-67 标记指数与归一化 ICVF 和 ODI 呈正相关(r = 0.755 和 0.572,P < 0.001),与归一化 ADC 呈负相关(r = -0.709,P < 0.001)。
NODDI 是一种有前途的胶质瘤分级和预测细胞增殖的方法。这些结果对胶质瘤的临床诊断和治疗可能具有重要意义。